Gefitinib plus docetaxel in non-small-cell lung cancer/Authors' reply

[...] this analysis would exclude different numbers and types of patients from each group and would not be a balanced randomised comparison. Oral gefitinib indeed has a similar efficacy to intravenous docetaxel, but better tolerability and quality of life. [...] treating with gefitinib first could be advantageous in providing patients with the opportunity for improved tolerability and quality of life without compromising efficacy.